Intracranial Hemorrhage Diagnosis & Treatment Market Research Report—Forecast to 2027
Global Intracranial Hemorrhage Diagnosis & Treatment Market is expected to witness a CAGR of 5.98% during the research period of 2020 to 2027. Intracranial hemorrhage is intense bleeding inside the skull or brain which results in a life-threatening emergency. lead to an increase in intracranial pressure, which can further damage brain tissues. The global market growth is mainly attributed to the rising prevalence of aneurysms, the growing number of road accidents, and the rising expenditure on healthcare infrastructure. Furthermore, the increased funding for the research and treatment of intracranial hemorrhage drives the growth of the market.
The Global Intracranial Hemorrhage Diagnosis & Treatment Market is anticipated to register a healthy market growth owing to the largest market value of USD 1,493.98 Million in 2019. Additionally, the geriatric population and age-related brain disorders also raise the number of patients in need of diagnostic tools required for assessing the types of hemorrhage. However, the rising availability of counterfeit drugs & complications associated with the surgery and lack of awareness about the available treatments is expected to restrain the growth of the global market during the review period.
Global Intracranial Hemorrhage Diagnosis & Treatment Market has been classified into Type and Diagnosis & Treatment.
Based on product segment, the market has been classified into intracerebral hemorrhage, subarachnoid hemorrhage, epidural hematoma, and subdural hematoma.
In terms of diagnosis & treatment segment, the intracranial hemorrhage diagnosis & treatment market has been divided into diagnosis and treatment. The diagnosis segment has been further divided into CT, MRI, and others. The treatment segment has been further bifurcated into medication and surgery. In terms of medication type, the global market is further classified into anti-hypertensive drugs, coagulants, and others. However, based on surgery, the market is further classified as decompression surgery, craniotomy with open surgery, endoscopic evacuation, stereotactic aspiration, and clipping or coiling procedures.
Geographically, the Global Intracranial Hemorrhage Diagnosis & Treatment Market has been segmented into the Americas, Europe, Asia-Pacific, and Middle East & Africa.
The Americas is expected to contribute the largest share of the global intracranial hemorrhage diagnosis & treatment market during the review period. The regional market is attributed to the well-established healthcare sector, increased expenditure on research, rapid adoption of advanced treatment, and the presence of leading players in the region.
The European market is anticipated to exhibit the second largest market due to the advanced treatment facilities, rising government initiatives to promote research, rising number of trauma cases, and increasing number healthcare spending. Asia-Pacific is anticipated to register substantial market growth during the review period. The regional market growth is attributed to the rising R&D funding by developing countries such as China and India for the development of the healthcare infrastructure.
The Key Players in the Global Intracranial Hemorrhage Diagnosis & Treatment Market include Canon Inc. (Japan), FUJIFILM Holdings Corporation (Japan), GE Healthcare (US), Hitachi Ltd. (Japan), Infrascan, inc. (US), Johnson & Johnson (US), Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), Siemens AG (Germany), Stryker Corporation (US) and Others.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.